Antibodies to c3b(i) for delivery of diagnostic and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 38/17 (2006.01) A61K 48/00 (2006.01) A61K 51/10 (2006.01) C07K 16/18 (2006.01) C07K 16/28 (2006.01) C07K 16/30 (2006.01) G01N 33/574 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2342601

The present invention relates to the treatment, inhibition and prevention of cancer by the administration of anti-C3b(i) antibodies. The invention also relates to the treatment, inhibition and prevention of cancer by the administration of IgM antibodies and/or complement components prior to the administration of anti-C3b(1) antibodies. The present invention further relates to the detection, imaging, diagnosis and monitoring of cancer utilizing C3b(i) specific antibodies.

La présente invention concerne le traitement, l'inhibition et la prévention d'un cancer par administration d'anticorps anti-C3b(i). L'invention concerne également le traitement, l'inhibition et la prévention d'un cancer par administration d'anticorps IgM et/ou de composants du complément préalablement à l'administration d'anticorps anti-C3b(i). L'invention concerne en outre le dépistage, l'imagerie, le diagnostic et la surveillance d'un cancer au moyen d'anticorps spécifiques du C3b(i).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antibodies to c3b(i) for delivery of diagnostic and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies to c3b(i) for delivery of diagnostic and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to c3b(i) for delivery of diagnostic and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1630976

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.